Evidence map›Paper›PMID 23838598›Full record

ReviewEuropean journal of human genetics : EJHG2014

Atrial fibrillation: the role of common and rare genetic variants.

Morten S Olesen, Morten W Nielsen, Stig Haunsø, Jesper H Svendsen

Open access · bronzeAbstract readReview
In one paragraph

Review in European journal of human genetics : EJHG, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 1 pooled it
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 1 synthesis or guideline pooled it, 113 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Common Methylenetetrahydrofolate Reductase PolymorphismDiagnostics (Basel, Switzerland) · 2025
    Article
  5. Article
  6. aTrial arrhythmias in inhEriTed aRrhythmIa Syndromes: results from the TETRIS study.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2024
    Article
  7. Article
  8. Review
  9. Article
  10. Genetic testing in monogenic early-onset atrial fibrillation.European journal of human genetics : EJHG · 2023
    Article
  11. Article
  12. Article
  13. Article
  14. Effect of Occurrence of Lamin A/C (Frontiers in cardiovascular medicine · 2022
    Article
  15. Article
  16. Review
  17. Atrial fibrillation-a complex polygenetic disease.European journal of human genetics : EJHG · 2021
    Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Morten S Olesen1] The Danish National Research Foundation Centre for Cardiac Arrhythmia (DARC), Copenhagen, Denmark [2] Laboratory for Molecular Cardiology, The Heart Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Morten W Nielsen1] The Danish National Research Foundation Centre for Cardiac Arrhythmia (DARC), Copenhagen, Denmark [2] Laboratory for Molecular Cardiology, The Heart Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Stig Haunsø1] The Danish National Research Foundation Centre for Cardiac Arrhythmia (DARC), Copenhagen, Denmark [2] Laboratory for Molecular Cardiology, The Heart Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark [3] Department of Surgery and Medicine, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.
Jesper H Svendsen1] The Danish National Research Foundation Centre for Cardiac Arrhythmia (DARC), Copenhagen, Denmark [2] Laboratory for Molecular Cardiology, The Heart Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark [3] Department of Surgery and Medicine, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.
University of Copenhagen · DKDanish National Research Foundation · DKRigshospitalet · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Atrial fibrillation (AF) is the most common cardiac arrhythmia affecting 1-2% of the general population. A number of studies have demonstrated that AF, and in particular lone AF, has a substantial genetic component. Monogenic mutations in lone and familial AF, although rare, have been recognized for many years. Presently, mutations in 25 genes have been associated with AF. However, the complexity of monogenic AF is illustrated by the recent finding that both gain- and loss-of-function mutations in the same gene can cause AF. Genome-wide association studies (GWAS) have indicated that common single-nucleotide polymorphisms (SNPs) have a role in the development of AF. Following the first GWAS discovering the association between PITX2 and AF, several new GWAS reports have identified SNPs associated with susceptibility of AF. To date, nine SNPs have been associated with AF. The exact biological pathways involving these SNPs and the development of AF are now starting to be elucidated. Since the first GWAS, the number of papers concerning the genetic basis of AF has increased drastically and the majority of these papers are for the first time included in a review. In this review, we discuss the genetic basis of AF and the role of both common and rare genetic variants in the susceptibility of developing AF. Furthermore, all rare variants reported to be associated with AF were systematically searched for in the Exome Sequencing Project Exome Variant Server.

Indexed as

Atrial FibrillationGenetic LociHomeobox Protein PITX2Homeodomain ProteinsHumansPolymorphism, Single NucleotideTranscription FactorsHomeobox Protein PITX2Homeodomain ProteinsTranscription Factors

Identifiers

PMID23838598
PMCPMC3925267
OpenAlexW1983977742

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.